The Frobozz Magic Companies

/ Good Stuff for Everybody /

We make things better through data

For any successful technology, or any successful reorganization of the way we work together on this planet, reality must take precedence over public relations. Nature cannot be fooled. We must go where the data lead us and damn the fools who ignore it.

Always Making it Better

20 years at GSK, in R&D and Corporate roles. Stints at Biogen, Wyeth-Ayerst, and MannKind. Now a Strategic Consultant for Healthcare at Ab Initio. No. I'm not looking, I'm having too much fun.

Challenges Met

Redesigning of Clinical Programs for OptumRX (UHG) / Migration of Pharma Plans between adjudication platforms (Express Scripts) / Detecting Medical & Pharma Claims Fraud, Waste, & Abuse (Various) / $1.8bn in Savings from Optimized Procurement Processes (GSK)

Awards & Honors

Master Black Belt in Lean Six Sigma. First class to graduate with Heathcare Focus [Villanova] / Queen's Award for Technology [Hep B Vaccine] / MBA with concentrations in both International Business & Information Technology [McGill] / Completed 3 degrees in 4 ½ years: MS Biochemical Engineering, BS Chemical Engineering, BS Biology [MIT] / NSF Fellowship / Karl Taylor Compton Prize [MIT]

Gerry Fitzgerald

Data Scientist, Biochemical Engineer

Doing precision guesswork based on unreliable data provided by those of questionable knowledge.

DOWNLOAD MY CV

MY SKILL SET


Lean Six Sigma Master Black Belt 30%
30% Complete (success)
MBA International Business & IT 25%
25% Complete (warning)
CISA 20%
20% Complete (danger)
Ab Initio Coding 15%
15% Complete (success)
Bartending 10%
10% Complete (warning)

CURRENT RESEARCH

I'm currently researching Healthcare Fraud, Waste, & Abuse

COMPANY : Undisclosed


Opioid Overuse, Drug Interactions, Gaps in Care.


What I'm Reading

Publications & Patents

Gerald L. Fitzgerald, “Implementing and Deploying a Groupware Environment Throughout Pharmaceutical R&D,” PharmAnalysis Conference, Atlantic City, NJ, June 1995.

Gerald L. Fitzgerald, "Future of Automated Chromatography Systems," Perkin Elmer Laboratory Systems Symposium, Tokyo, Japan, 1993.

Gerald L. Fitzgerald, "The Role of Metrics in Computer Systems Validation," 1992 Pharmaceutical Manufacturers' Association Analytical Subcommittee Meeting, Denver, CO.

Gerald L. Fitzgerald and James D. Swanson, "Measuring the Effects of Laboratory Automation: the value of empirical models," J. Auto Chem, 14 (1992) 55-57.

Gerald L. Fitzgerald, William J. Cassano, Karl K. Soneson, Frank L. Tobin, and Preston Hensley, "Development of a Data Acquisition and Analysis System for Measuring Protein Binding Constants Through Ultracentrifugation," 1990 Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy.

Gerald L. Fitzgerald and James D. Swanson, "Measuring the Effects of Laboratory Automation," 1991 Federation of Analytical Chemistry and Spectroscopy Societies, Anaheim, CA.

Robert J. Linhardt, Gerald L. Fitzgerald, Charles L. Cooney, and Robert Langer, "Mode of Action of Heparin Lyase on Heparin," Biochemica et Biophysica Acta, 702, (1982) 197-203.

Arthur C. Grant, Robert J. Linhardt, Gerald L. Fitzgerald, Janice J. Park, and Robert Langer, "Metachromatic Activity of Heparin and Heparin Fragments," Analytical Biochemistry, 132, (1984) 25-32.

Robert J. Linhardt, Zohar M. Merchant, Kevin G. Rice, Yeong S. Kim, Gerald L. Fitzgerald, Arthur C. Grant, and Robert Langer, "Evidence of Random Structural Features in the Heparin Polymer," Biochemistry, 24, (1985) 7805-7810.

US Patent #4,396,762   Heparinase Derived Anticoagulants

US Patent #4,341,869   Process for Producing Heparinase

US Patent #4,373,023   Process and Composition for Neutralizing Heparin

Lecturer on Laboratory Automation at Medical College of Pennsylvania, 1990

Address: 509 S Chickasaw Trl, Orlando, FL 32825-7801
Phone: (407) 346-6647 / (203) 702-0644
e-mail: gerry.fitzgerald@frobozzmagic.com